Document is current

Article History

Received: 30 December 2024

Accepted: 12 April 2025

First Online: 23 April 2025

Declarations

:

: This project was deemed quality improvement (QI) by the Boston Children’s Hospital Department of Pediatrics Performance Excellence Group. QI projects that are designed to improve clinical care to better conform to established or accepted standards are considered exempt from human subject’s review by our institutional review board.

: Not applicable.

: MCM, RL, MS, DK, DW, RB, JA have no conflict of interest and no financial disclosure. MD and SB are faculty for Healthcare Systems Simulation International, which provided consulting services. MS is a consultant for Impact Advisors which provided consulting services. Dr. Eliot Shearer is the principal investigator for a sponsor-initiated clinical trial (IRB-P00046118) that is also sponsored by Akouos (a fully owned subsidiary of Eli Lily). He is also a member of the scientific advisory board for Akouos. However, he receives no compensation or incentive from this relationship and has no personal financial interest in Eli Lily or Akouos. There are no other competing interests from the author team, and none disclosed that influence the content of this paper.